VistaGen Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing various medicines with the potential to care for anxiety, depression, and other disorders of the central nervous system (CNS). The company's CNS pipeline includes PH94B, a rapid-onset neuroactive nasal spray, which is in Phase III development for the acute treatment of anxiety in adults with social anxiety disorder. Its PH94B product candidature also has potential to treat a range of anxiety disorders, including adjustment disorder with anxiety, postpartum anxiety, post-traumatic stress disorder, preprocedural anxiety, and panic disorders. The company's CNS pipeline also comprises PH10, a rapid-onset neuroactive nasal spray, which is in preparation for Phase 2B clinical development as a stand-alone treatment for major depressive disorder (MDD); and AV-101, an oral N-methyl-D-aspartate receptor antagonist, which is in development in combination with oral probenecid as a potential treatment of levodopa-induced dyskinesia, MDD, neuropathic pain, and suicidal ideation. It has contract research and development agreement with Cato Research Ltd.; license agreement with Pherin Pharmaceuticals, Inc.; and license and collaboration agreement with EverInsight Therapeutics Inc. VistaGen Therapeutics, Inc. was founded in 1998 and is headquartered in South San Francisco, California. The 2025 version of the report offers detailed insights into the company's strategies, developments, outlook and drivers. In addition to SWOT Analysis and Financial Overview, the report analyzes key projects, business description, products, services, brands, operating locations, subsidiaries and affiliates of VistaGen Therapeutics Inc..
VistaGen Therapeutics Inc. business operations across the value chain are included. Further, all major operating and planned locations, related contacts, details of subsidiaries and partnerships of VistaGen Therapeutics Inc. are also analyzed.
Detailed
SWOT Analysis of the company including key strengths and weaknesses of VistaGen Therapeutics Inc. , on which it can build its business along with potential opportunities and threats in the near to medium term future are detailed.
Key employees of the company including the management team and board of directors are listed with their designations. Further, statistics on key parameters such as employee count, organization structure etc is provided.
Financial analysis of VistaGen Therapeutics Inc. including key ratios, income statement, cash flow statement and balance sheet are provided for the company. In addition, Key historical events, summary analysis of VistaGen Therapeutics Inc. and all latest updates of the company are provided.
The 2025 version of VistaGen Therapeutics Inc. report is presented after intensive primary and secondary research processes and it presents the insights in a complete impartial and reader friendly format.
TABLE OF CONTENTS
1.1 List of Tables
1.2 List of Figures
2 Introduction to the Company
2.1 VistaGen Therapeutics Inc.- Key Facts
2.2 VistaGen Therapeutics Inc.- Geographic Locations
2.3 VistaGen Therapeutics Inc.- Subsidiaries and Affiliates
2.4 VistaGen Therapeutics Inc.- Business Divisions
2.5 VistaGen Therapeutics Inc.- Key Employees
2.5.1 Management Team
2.5.2 Board of Directors
3. VistaGen Therapeutics Inc. Strategic Analysis Review
3.1 VistaGen Therapeutics Inc.- Key Strategies
3.2 VistaGen Therapeutics Inc.- Company Outlook Statement
3.3 VistaGen Therapeutics Inc.- SWOT Analysis
3.3.1 VistaGen Therapeutics Inc.- Key Strengths
3.3.2 VistaGen Therapeutics Inc.- Key Weaknesses
3.3.3 VistaGen Therapeutics Inc.- Potential Opportunities
3.3.4 VistaGen Therapeutics Inc.- Potential Threats
3.4 VistaGen Therapeutics Inc.- Key Competitors
4. Business Description of the Company
4.1 VistaGen Therapeutics Inc.- Business Overview
4.2 VistaGen Therapeutics Inc.- Operations by Segment
5 Products and Services Details
5.1 VistaGen Therapeutics Inc.- Key Products
5.2 VistaGen Therapeutics Inc.- Key Service Areas
5.3 VistaGen Therapeutics Inc.- Key Brands
6 Company Developments
6.1 VistaGen Therapeutics Inc.- Company History
6.2 VistaGen Therapeutics Inc.- Latest Developments
7 Financial Analysis
7.1 VistaGen Therapeutics Inc.- Income Statements
7.2 VistaGen Therapeutics Inc.- Balance Sheet
7.3 VistaGen Therapeutics Inc.- Cash Flow Statements
8 Competitors and Industry Analysis
8.1 VistaGen Therapeutics Inc.- Direct Competitors
8.2 VistaGen Therapeutics Inc.- Competitor Financial Ratios comparison
8.3 VistaGen Therapeutics Inc.- Competitor Stock Charts Comparison
8.4 VistaGen Therapeutics Inc.- Industry Analysis
9 Appendix
9.1 About SWOTreports
9.2 Sources and Methodology
9.3 Contact Information
P.S.Financial Analysis will be provided only for companies reporting financial data.
At SWOT Reports, we understand the importance of informed decision-making in today's dynamic business landscape. To help you experience the depth and quality of our market research reports, we offer complimentary samples tailored to your specific needs.
Start Now! Please fill the form below for your free sample.
Evaluate Our Expertise: Our reports are crafted by industry experts and seasoned analysts. Requesting a sample allows you to assess the depth of research and the caliber of insights we provide.
Tailored to Your Needs: Let us know your industry, market segment, or specific topic of interest. Our free samples are customized to ensure relevance to your business objectives.
Witness Actionable Insights: See firsthand how our reports go beyond data, offering actionable insights and strategic recommendations that can drive your business forward.
Embark on your journey towards strategic decision-making by requesting a free sample from SWOT Reports. Experience the caliber of insights that can transform the way you approach your business challenges.
Gain valuable insights into the company for academic or business research purposes with this comprehensive profile. Key elements, such as SWOT analysis and corporate strategy, are included to support your research needs effectively.
Customer and Supplier Identification: Analyze the company’s business structure, operations, major products, services, and strategies to identify potential customers and suppliers.
Leverage a detailed SWOT analysis to understand and evaluate your competitors' business structures, strategies, and core performance metrics. This analysis offers an up-to-date and objective perspective on the company’s strengths, weaknesses, opportunities, and threats.
Didn’t find what you’re looking for? TALK TO OUR ANALYST TEAM
Need something within your budget? NO WORRIES! WE GOT YOU COVERED!